149193-64-6

Upstream product

• 79069-16-2 benzyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-hydroxybutanoate 
• 124-63-0 methanesulfonyl chloride 
• 883998-10-5 (S)-benzyl 3-(tert-butoxycarbonylamino)-4-(3,4-dichlorophenylthio)-butanoate 
• 7536-58-5 BOC-L-aspartic acid 4-benzyl ester 

Downstream Products

• 517877-34-8 (S)-N-[(tert-butoxy)carbonyl]-γ-[N⁴-(benzyloxycarbonyl)cytosin-1-yl]-β-homoalanine benzyl ester 
• 883998-10-5 (S)-benzyl 3-(tert-butoxycarbonylamino)-4-(3,4-dichlorophenylthio)-butanoate 
• 517877-35-9 (S)-N-[(tert-butoxy)carbonyl]-γ-[N⁴-(benzyloxycarbonyl)cytosin-1-yl]-β-homoalanine 
• 517877-32-6 (S)-N-[(tert-butoxy)carbonyl]-γ-(3-benzoylthymin-1-yl)-β-homoalanine benzyl ester 

Relevant academic research and scientific papers

SUBSTITUTED SULFONES AND METHODS OF USE

Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Nucleo-β-amino acids: Synthesis and oligomerization to β-homoalanyl-PNA

The synthesis of thyminyl-, uracilyl-, cytosinyl-, and guaninyl-β3-amino acids and the oligomerization of the cytosinyl- and guaninyl-β3-amino acids to β-homoalanyl-PNA are presented. The pyrimidinyl nucleobases were connected to the